US Supreme Court to review whether generics firms have to add side-effect threats to labels
This article was originally published in Scrip
Executive Summary
The US Supreme Court has agreed to clarify the legal duty of makers of generic medicines to change their labels to warn consumers of a new threat of harmful side-effects, and to decide whether state court lawsuits may be filed for failure to do so, according to Scotusblog, which reviews Supreme Court dealings.